Diagnostics and Therapy of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitides

E-ISSN： 1873-4286|18|29|4537-4541

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.29, 2012-10, pp. : 4537-4541

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antineutrophil Cytoplasmic Antibody-Positive Vasculitis Associated with Propylthiouracil Therapy

By Dinmezel S. Ogus C. özdemir T.

Clinical Drug Investigation, Vol. 23, Iss. 12, 2003-01 ,pp. : 817-821

Adis International

Access to resources Recommend Favorite

Mycophenolate mofetil (MMF) effectively treats antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Respiratory System Involvement in Antineutrophil Cytoplasmic-Associated Systemic Vasculitides: Clinical, Pathological, Radiological and Therapeutic Considerations

By Pesci Alberto

Drugs in R&D, Vol. 8, Iss. 1, 2007-01 ,pp. : 25-42

Adis International

Access to resources Recommend Favorite

Novel Therapies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

By Lee Richard W. D'Cruz David P.

Drugs, Vol. 68, Iss. 6, 2008-01 ,pp. : 747-770

Adis International

Access to resources Recommend Favorite

Mouse Models of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. : 2380-2390

Bentham Science Publishers

Access to resources Recommend Favorite